arry-520 and carfilzomib

arry-520 has been researched along with carfilzomib* in 1 studies

Trials

1 trial(s) available for arry-520 and carfilzomib

ArticleYear
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
    Blood cancer journal, 2019, 10-01, Volume: 9, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Oligopeptides; Progression-Free Survival; Thiadiazoles

2019